BFM
IMCR icon

Boothbay Fund Management’s Immunocore IMCR Stock Holding History

Boothbay Fund Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.38M Buy
+295,546
New +$8.74M 0.12% 178
2021
Q4 		– Sell
-6,826
Closed -$253K – 2018
2021
Q3 		$253K Buy
6,826
+770
+13% +$26K 0.01% 1420
2021
Q2 		$236K Buy
+6,056
New +$234K 0.01% 1417

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Boothbay Fund Management's IMCR Position: Q2 2026 in Review

Boothbay Fund Management opened a new position in Immunocore (IMCR) in Q2 2026: 295,546 shares worth $9.38M. The stake represents 0.12% of the portfolio and ranks #178 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in IMCR as recently as Q3 2021.

Boothbay Fund Management first reported a position in IMCR in Q2 2021 and has held it in 3 quarters since. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Boothbay Fund Management held 295,546 shares of Immunocore worth $9.38M as of Q2 2026.
  • Immunocore was a new Boothbay Fund Management position in Q2 2026.
  • Immunocore made up 0.12% of Boothbay Fund Management's portfolio in Q2 2026, its #178 holding.
  • Boothbay Fund Management first reported a position in Immunocore in Q2 2021 and has held it in 3 quarters since.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.